Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment

Inclusion Criteria: * Common cold: presence of moderate to severe nasal congestion AND moderate to severe runny nose AND at least one (01) of the following moderate to severe symptoms: sneezing, headache, myalgia, sore throat, throat pain, dysphonia, cough and fever. Duration of symptoms ≤ 48 hours at screening. Informed Consent Form (ICF) signed before carrying out any study procedure. Exclusion Criteria: * Presence of significant septum deviation, compatible with impaired nasal ventilatory function, at the investigator's discretion. * Presence of nasal polyposis to previous rhinoscopy. * Known hypersensitivity to any component of the experimental drug formulation. * Required antibiotic therapy for upper airway infection treatment